KLF9 and prostate cancer: Underscoring the emerging role KFL9 in hormone-responsive neoplasms, knockout of Klf9 in mice increased overall endometrial carcinoma burden [65], while its ectopic expression promoted apoptosis in androgen-dependent prostate cancer cells [66] and restricted BCa metastatic spread [20].